Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

Newly designed proteins can effectively degrade specific proteins in cells, offering a promising alternative for targeted protein degradation.

A new TP63 mutation was found in a baby with EEC syndrome, showing the need for TREC testing to check for immune issues.

Skin's Regulatory T cells are crucial for maintaining skin health and could be targeted to treat immune-related skin diseases and cancer.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Certain immune cells may cause hair loss by reacting to stressed hair follicles.

Cells from a skin condition can create new hair follicles and similar growths in mice, and a specific treatment can reduce these effects.

TSC2-/meth cells can cause skin lesions, hair growth, and lung issues, and may be treated with chromatin remodeling agents.

HTLV-1-associated lichenoid dermatitis (HALD) is linked to an immune response against HTLV-1-infected cells.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

MAIT cells may help fight COVID-19 but also contribute to severe inflammation.

Epidermal resident memory T cells play a crucial role in skin immunity and disease understanding.

CD8+ T cells re-expressing CD45RA may predict treatment resistance in severe alopecia areata.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Tph cells are linked to the severity of systemic lupus erythematosus.

People with alopecia areata have fewer regulatory T-cells than those with other skin conditions.

BTNL proteins help control inflammatory bowel disease by maintaining specific immune cells.

Melanoma cells lose their ability to form tumors when placed in a zebrafish embryo environment.

Fetal skin has unique immune cells different from adult skin.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Gamma/delta T cells help defend skin against heavy metals.

T cells show stress responses in alopecia areata, suggesting potential treatment targets.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

Overexpressing Merkel cell virus proteins in human hair follicles can create clusters of cells that resemble Merkel cell cancer.

Removing certain immune cells in mice causes their hair to enter the growth phase earlier than usual.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Alopecia areata patients have more activated T cells in their blood, which may help in developing treatments.